Suppr超能文献

大鼠和人类载脂蛋白C对灌注大鼠肝脏摄取富含甘油三酯的脂蛋白及其残粒的抑制作用。

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

作者信息

Windler E, Havel R J

出版信息

J Lipid Res. 1985 May;26(5):556-65.

PMID:4020294
Abstract

Like rat C apolipoproteins, each of the C apolipoproteins from human blood plasma (C-I, C-II, C-III-1, and C-III-2) bound to small chylomicrons from mesenteric lymph of estradiol-treated rats and inhibited their uptake by the isolated perfused rat liver. This inhibitory effect of the C apolipoproteins was independent of apolipoprotein E, which is present only in trace amounts in these chylomicrons. Addition of rat apolipoprotein E to small chylomicrons from mesenteric lymph of normal rats did not displace C apolipoproteins and had no effect on the uptake of these particles by the perfused liver, indicating that an increased ratio of E apolipoproteins to C apolipoproteins on chylomicron particles, unaccompanied by depletion of the latter, may not promote recognition by the chylomicron remnant receptor. The hepatic uptake of remnants of rat hepatic very low density lipoproteins (VLDL) and small chylomicrons, which had been produced in functionally eviscerated rats, was also inhibited by addition of C apolipoproteins. These observations are consistent with the hypothesis that the addition of all of the C apolipoproteins to newly secreted chylomicrons and VLDL inhibits premature uptake of these particles by the liver and that depletion of all of these apolipoproteins from remnant particles facilitates their hepatic uptake. Remnants of chylomicrons and VLDL incubated with rat C apolipoproteins efficiently took up C-III apolipoproteins, but not apolipoprotein C-II (the activator protein for lipoprotein lipase). Preferential loss of apolipoprotein C-II during remnant formation may regulate the termination of triglyceride hydrolysis prior to complete removal of triglycerides from chylomicrons and VLDL.

摘要

与人血浆中的载脂蛋白C(C-Ⅰ、C-Ⅱ、C-Ⅲ-1和C-Ⅲ-2)一样,来自雌二醇处理大鼠肠系膜淋巴的载脂蛋白C与小乳糜微粒结合,并抑制其被分离的灌注大鼠肝脏摄取。载脂蛋白C的这种抑制作用与载脂蛋白E无关,后者在这些乳糜微粒中仅微量存在。向正常大鼠肠系膜淋巴的小乳糜微粒中添加大鼠载脂蛋白E不会取代载脂蛋白C,对灌注肝脏摄取这些颗粒也没有影响,这表明乳糜微粒颗粒上E载脂蛋白与C载脂蛋白的比例增加,而后者没有减少,可能不会促进乳糜微粒残粒受体的识别。添加载脂蛋白C也会抑制功能性去内脏大鼠产生的大鼠肝极低密度脂蛋白(VLDL)残粒和小乳糜微粒的肝脏摄取。这些观察结果与以下假设一致:向新分泌的乳糜微粒和VLDL中添加所有载脂蛋白C会抑制肝脏对这些颗粒的过早摄取,而残粒颗粒中所有这些载脂蛋白的减少则有助于它们被肝脏摄取。与大鼠载脂蛋白C一起孵育的乳糜微粒和VLDL残粒有效地摄取了载脂蛋白C-Ⅲ,但没有摄取载脂蛋白C-Ⅱ(脂蛋白脂肪酶的激活蛋白)。在残粒形成过程中载脂蛋白C-Ⅱ的优先丢失可能在从乳糜微粒和VLDL中完全去除甘油三酯之前调节甘油三酯水解的终止。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验